These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 7479396)
1. Stimulation of human prostate cancer cell lines by factors present in human osteoblast-like cells but not in bone marrow. Lang SH; Miller WR; Habib FK Prostate; 1995 Nov; 27(5):287-93. PubMed ID: 7479396 [TBL] [Abstract][Full Text] [Related]
2. Prostate cancer cells induce osteoblast differentiation through a Cbfa1-dependent pathway. Yang J; Fizazi K; Peleg S; Sikes CR; Raymond AK; Jamal N; Hu M; Olive M; Martinez LA; Wood CG; Logothetis CJ; Karsenty G; Navone NM Cancer Res; 2001 Jul; 61(14):5652-9. PubMed ID: 11454720 [TBL] [Abstract][Full Text] [Related]
3. Human prostatic cancer cells, PC3, elaborate mitogenic activity which selectively stimulates human bone cells. Perkel VS; Mohan S; Herring SJ; Baylink DJ; Linkhart TA Cancer Res; 1990 Nov; 50(21):6902-7. PubMed ID: 1698544 [TBL] [Abstract][Full Text] [Related]
4. Human prostatic tumor cells in culture produce growth and differentiation factors active on osteoblasts: a new biological and clinical parameter for prostatic carcinoma. Festuccia C; Teti A; Bianco P; Guerra F; Vicentini C; Tennina R; Villanova I; Sciortino G; Bologna M Oncol Res; 1997; 9(8):419-31. PubMed ID: 9436195 [TBL] [Abstract][Full Text] [Related]
5. Prostate cancer cells-osteoblast interaction shifts expression of growth/survival-related genes in prostate cancer and reduces expression of osteoprotegerin in osteoblasts. Fizazi K; Yang J; Peleg S; Sikes CR; Kreimann EL; Daliani D; Olive M; Raymond KA; Janus TJ; Logothetis CJ; Karsenty G; Navone NM Clin Cancer Res; 2003 Jul; 9(7):2587-97. PubMed ID: 12855635 [TBL] [Abstract][Full Text] [Related]
6. Resveratrol pretreatment desensitizes AHTO-7 human osteoblasts to growth stimulation in response to carcinoma cell supernatants. Ulsperger E; Hamilton G; Raderer M; Baumgartner G; Hejna M; Hoffmann O; Mallinger R Int J Oncol; 1999 Nov; 15(5):955-9. PubMed ID: 10536179 [TBL] [Abstract][Full Text] [Related]
7. Effects of 1alpha,25-dihydroxy-vitamin D3 pretreatment and MAP kinase inhibitor PD 98059 on response of osteoblasts to prostate-derived osteoblastic factors. Ulsperger E; Hamilton G; Olszewski U; Baumgartner G; Engel A; Mallinger R Oncol Rep; 2003; 10(5):1529-34. PubMed ID: 12883736 [TBL] [Abstract][Full Text] [Related]
8. Modulation of CD99/MIC2 expression of human AHTO-7 osteoblasts by carcinoma cell line-conditioned media. Hamilton D; Mallinger R; Millesi H; Engel A; Baumgartner G; Raderer M Anticancer Res; 2001; 21(6A):3909-13. PubMed ID: 11911268 [TBL] [Abstract][Full Text] [Related]
9. Production and response of human prostate cancer cell lines to granulocyte macrophage-colony stimulating factor. Lang SH; Miller WR; Duncan W; Habib FK Int J Cancer; 1994 Oct; 59(2):235-41. PubMed ID: 7927924 [TBL] [Abstract][Full Text] [Related]
10. Therapeutic implications of enhanced G(0)/G(1) checkpoint control induced by coculture of prostate cancer cells with osteoblasts. Pinski J; Parikh A; Bova GS; Isaacs JT Cancer Res; 2001 Sep; 61(17):6372-6. PubMed ID: 11522628 [TBL] [Abstract][Full Text] [Related]
11. Stimulation of human prostatic carcinoma cell growth by factors present in human bone marrow. Chackal-Roy M; Niemeyer C; Moore M; Zetter BR J Clin Invest; 1989 Jul; 84(1):43-50. PubMed ID: 2786890 [TBL] [Abstract][Full Text] [Related]
12. Osteoblast-conditioned media stimulate membrane vesicle shedding in prostate cancer cells. Millimaggi D; Festuccia C; Angelucci A; D'Ascenzo S; Rucci N; Flati S; Bologna M; Teti A; Pavan A; Dolo V Int J Oncol; 2006 Apr; 28(4):909-14. PubMed ID: 16525640 [TBL] [Abstract][Full Text] [Related]
13. Vascular endothelial growth factor contributes to prostate cancer-mediated osteoblastic activity. Kitagawa Y; Dai J; Zhang J; Keller JM; Nor J; Yao Z; Keller ET Cancer Res; 2005 Dec; 65(23):10921-9. PubMed ID: 16322239 [TBL] [Abstract][Full Text] [Related]
14. Secretory products of breast cancer cells specifically affect human osteoblastic cells: partial characterization of active factors. Siwek B; Lacroix M; De Pollak C; Marie P; Body JJ J Bone Miner Res; 1997 Apr; 12(4):552-60. PubMed ID: 9101366 [TBL] [Abstract][Full Text] [Related]
15. Bi-directional interactions of prostate cancer cells and bone marrow endothelial cells in three-dimensional culture. Barrett JM; Mangold KA; Jilling T; Kaul KL Prostate; 2005 Jun; 64(1):75-82. PubMed ID: 15651029 [TBL] [Abstract][Full Text] [Related]
16. The effects of growth factors associated with osteoblasts on prostate carcinoma proliferation and chemotaxis: implications for the development of metastatic disease. Ritchie CK; Andrews LR; Thomas KG; Tindall DJ; Fitzpatrick LA Endocrinology; 1997 Mar; 138(3):1145-50. PubMed ID: 9048621 [TBL] [Abstract][Full Text] [Related]
17. Tumour-stroma interactions between metastatic prostate cancer cells and fibroblasts. Kaminski A; Hahne JC; Haddouti el-M; Florin A; Wellmann A; Wernert N Int J Mol Med; 2006 Nov; 18(5):941-50. PubMed ID: 17016625 [TBL] [Abstract][Full Text] [Related]
18. A better defined medium for human prostate cancer cells. Pretlow TG; Ogrinc GS; Amini SB; Delmoro CM; Molkentin KF; Willson JK; Pretlow TP In Vitro Cell Dev Biol Anim; 1993 Jul; 29A(7):528-30. PubMed ID: 8354663 [No Abstract] [Full Text] [Related]
19. Acceleration of human prostate cancer growth in vivo by factors produced by prostate and bone fibroblasts. Gleave M; Hsieh JT; Gao CA; von Eschenbach AC; Chung LW Cancer Res; 1991 Jul; 51(14):3753-61. PubMed ID: 1712249 [TBL] [Abstract][Full Text] [Related]
20. Conditioned medium from osteocytes stimulates the proliferation of bone marrow mesenchymal stem cells and their differentiation into osteoblasts. Heino TJ; Hentunen TA; Väänänen HK Exp Cell Res; 2004 Apr; 294(2):458-68. PubMed ID: 15023534 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]